CIC
GH icon

Carnegie Investment Counsel’s Guardant Health GH Stock Holding History

Carnegie Investment Counsel’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22,959
Closed -$926K – 484
2022
Q2 		$926K Sell
22,959
-6,400
-22% -$317K 0.04% 269
2022
Q1 		$1.95M Sell
29,359
-12,725
-30% -$871K 0.07% 204
2021
Q4 		$4.21M Sell
42,084
-61,323
-59% -$6.34M 0.14% 150
2021
Q3 		$12.9M Sell
103,407
-31,220
-23% -$3.71M 0.49% 69
2021
Q2 		$16.7M Buy
134,627
+34,422
+34% +$4.63M 0.63% 54
2021
Q1 		$15.3M Buy
100,205
+5,238
+6% +$792K 0.64% 52
2020
Q4 		$12.2M Buy
94,967
+6,470
+7% +$744K 0.55% 60
2020
Q3 		$9.89M Buy
88,497
+5,245
+6% +$480K 0.51% 61
2020
Q2 		$6.75M Buy
83,252
+13,902
+20% +$1.12M 0.39% 78
2020
Q1 		$4.83M Buy
69,350
+3,345
+5% +$257K 0.34% 91
2019
Q4 		$5.16M Buy
66,005
+4,180
+7% +$301K 0.3% 100
2019
Q3 		$3.95M Buy
61,825
+9,410
+18% +$829K 0.25% 109
2019
Q2 		$4.53M Buy
52,415
+12,755
+32% +$974K 0.29% 102
2019
Q1 		$3.04M Buy
+39,660
New +$2.2M 0.21% 124

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Carnegie Investment Counsel's GH Position: Q3 2022 in Review

Carnegie Investment Counsel sold out of Guardant Health (GH) in Q3 2022, closing a stake of 22,959 shares — an estimated $926K sold.

Carnegie Investment Counsel first reported a position in GH in Q1 2019 and held it in 14 quarters. The position peaked at $16.7M in Q2 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

  • Carnegie Investment Counsel reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
  • Carnegie Investment Counsel sold 22,959 Guardant Health shares in Q3 2022, an estimated $926K.
  • Carnegie Investment Counsel first reported a position in Guardant Health in Q1 2019 and held it in 14 quarters.
  • Carnegie Investment Counsel's Guardant Health position peaked at $16.7M in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Carnegie Investment Counsel's 13F filing for Q3 2022, filed 14 Oct 2022.